1. Home
  2. NNNN vs PHIN Comparison

NNNN vs PHIN Comparison

Compare NNNN & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • PHIN
  • Stock Information
  • Founded
  • NNNN 2021
  • PHIN 2023
  • Country
  • NNNN Germany
  • PHIN United States
  • Employees
  • NNNN N/A
  • PHIN N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PHIN
  • Sector
  • NNNN Health Care
  • PHIN
  • Exchange
  • NNNN Nasdaq
  • PHIN Nasdaq
  • Market Cap
  • NNNN 2.2B
  • PHIN 2.1B
  • IPO Year
  • NNNN 2025
  • PHIN N/A
  • Fundamental
  • Price
  • NNNN $27.36
  • PHIN $52.63
  • Analyst Decision
  • NNNN
  • PHIN Buy
  • Analyst Count
  • NNNN 0
  • PHIN 5
  • Target Price
  • NNNN N/A
  • PHIN $57.20
  • AVG Volume (30 Days)
  • NNNN 39.8K
  • PHIN 372.5K
  • Earning Date
  • NNNN 04-28-2026
  • PHIN 10-28-2025
  • Dividend Yield
  • NNNN N/A
  • PHIN 2.06%
  • EPS Growth
  • NNNN N/A
  • PHIN N/A
  • EPS
  • NNNN 0.06
  • PHIN 2.18
  • Revenue
  • NNNN $8,185,146.00
  • PHIN $3,427,000,000.00
  • Revenue This Year
  • NNNN N/A
  • PHIN $2.50
  • Revenue Next Year
  • NNNN N/A
  • PHIN $1.55
  • P/E Ratio
  • NNNN $503.50
  • PHIN $24.02
  • Revenue Growth
  • NNNN 21.95
  • PHIN N/A
  • 52 Week Low
  • NNNN $5.18
  • PHIN $36.25
  • 52 Week High
  • NNNN $55.65
  • PHIN $59.88
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 54.26
  • PHIN 42.89
  • Support Level
  • NNNN $12.93
  • PHIN $51.78
  • Resistance Level
  • NNNN $25.20
  • PHIN $55.40
  • Average True Range (ATR)
  • NNNN 4.99
  • PHIN 1.22
  • MACD
  • NNNN 1.61
  • PHIN 0.07
  • Stochastic Oscillator
  • NNNN 73.40
  • PHIN 32.28

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

Share on Social Networks: